Stockscreener 앱 받기
88.77
2.36%
-2.15
시장 영업 전:
88.93
0.16
+0.18%
Spdr Biotech Etf 주식(XBI)의 최신 뉴스
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
(XBI) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Trading Systems Reacting to (XBI) Volatility - news.stocktradersdaily.com
Inside XBI: What The SPDR S&P Biotech ETF Offers Investors (NYSEARCA:XBI) - Seeking Alpha
Technical Reactions to XBI Trends in Macro Strategies - news.stocktradersdaily.com
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(XBI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Assessing the Political and Policy Risks in the 2028 U.S. Presidential Race and Their Impact on Health and Biotech Sectors - AInvest
Health and Human Services Secretary Robert F. Kennedy Jr. Disavows 2028 Presidential Run, Pledges Loyalty to Trump. - AInvest
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - MSN
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
7 Best Biotech ETFs to Buy Now - US News Money
ETF Talk: Create the Future with This ETF - Stock Investor
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
US Bancorp DE Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF - Nasdaq
Atria Wealth Solutions Inc. Sells 2,438 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 of the Best AI ETFs to Buy for 2025 - US News Money
Prasad’s FDA Return Adds to Leadership Turmoil at U.S. Health Agencies - Barron's
FDA Leadership Shifts and Their Impact on Biotech Valuations: Navigating Regulatory Risk in the Post-Vinay Prasad Era - AInvest
Regulatory Leadership Volatility: How FDA Reinstatements Reshape Biotech Investment Landscapes - AInvest
The AI-Driven Medtech Revolution: Why Heartflow's IPO Signals a Strategic Buy in a Shifting Market - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Sells 19,021 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
QQQ Tops Daily ETF Inflows - ETF.com
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - MSN
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Is It Time to Buy Biotech Stocks? - The Motley Fool
Healthcare Stocks Sent Mixed Signals As Deals And Politics Took Center Stage - Finimize
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank of New York Mellon Corp - Defense World
The World’s First AI Genome Editor - Brownstone Research
BBH- A Biotech Fund That's Ripe for a Major Turnaround - Yahoo Finance
(08/04/25) BBH: A Biotech Fund That’s Ripe for a Major Turnaround - moneyshow.com
SPDR S&P Biotech ETF (NYSEARCA:XBI) Sees Large Growth in Short Interest - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by LPL Financial LLC - Defense World
N.E.W. Advisory Services LLC Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Lyell Wealth Management LP Has $1.18 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
BREAKING: Surprise FDA Exit May Boost Biotech ETF XBI - AInvest
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
Letko Brosseau & Associates Inc. Has $3.24 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Cetera Investment Advisers Buys 5,604 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
IFP Advisors Inc Decreases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing - Money/ US News
(XBI) Trading Advice - news.stocktradersdaily.com
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Cerity Partners LLC - Defense World
Cerity Partners LLC Has $1.51 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Envestnet Asset Management Inc. Sells 16,015 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
M&T Bank Corp Has $446,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lowered by Stratos Wealth Partners LTD. - Defense World
SPDR S&P Biotech ETF Options Spot-On: On July 15th, 99,099 Contracts Were Traded, With 717.92K Open Interest - 富途牛牛
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. - Barron's
XBI ETF: Riding the Pharma-Biotech Consolidation Wave - AInvest
Biotech Stocks Are Ready to Rebound. 3 to Watch Now. - Barron's
(XBI) Investment Analysis and Advice - news.stocktradersdaily.com
Mixed Moves In Health And Biotech Funds - Finimize
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
0.78%
자본화:
|
볼륨(24시간):